Publication details

Pharmacokinetic profiling via dried blood spot sampling method

Authors

PELCOVÁ Marta KREJČÍŘOVÁ Eva JUŘICA Jan GLATZ Zdeněk

Year of publication 2022
Type Conference abstract
Citation
Description Pharmacokinetic profiles are still an inevitable part of preclinical safety studies. Nowadays, animal models are subjected to ethical standards to be carefully monitored and the principles of the 3Rs are required: replacement, reduction and refinement. Use of dried blood spot (DBS) samples, typically 20-50 µl, rather than the larger blood volumes required to obtain plasma samples, fully embraces the latter two principles of reduction and refinement. We optimized and validated RP-HPLC method (Kinetex C18 column, 100x3.0 mm, 2.6 µm, Phenomenex) hyphenated to mass spectrometry (maXis impact qTOF, Bruker Daltonics) for the determination of two antipsychotics (namely olanzapine and clozapine) and an antidepressant (mirtazapine) in rat DBS samples. The developed LC-MS method offers short analysis cycle time (13 min) with satisfactory sensitivity covering concentration range expected for a pharmacokinetic profile at chosen drug dose. DBS samples for all time points were acquired from just one body, quantified and resultant profiles were figured.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info